Clinical Trial Update: A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates completion of a Phase 1/2 study evaluating umbilical cord-derived mesenchymal stem cells in pediatric cerebral palsy and related…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Periventricular Leukomalacia

Drugs mentioned

• UC-MSCs (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Rohto Pharmaceutical Co., Ltd. | Conditions: Cerebral Palsy, Periventricular Leukomalacia | Phase 1, Phase 2 | Status: COMPLETED